{"nct_id":"NCT01677572","title":"Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease","status":"TERMINATED","status_verified_date":"2020-07","start_date":"2012-10-05","start_date_type":"ACTUAL","primary_completion_date":"2019-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2019-07-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BIIB"]}